大博醫療(002901.SZ):髖關節假體獲第三類醫療器械註冊證
格隆匯7月8日丨大博醫療(002901.SZ)宣佈,公司於近日取得國家藥監局頒發的一項第三類《醫療器械註冊證》。產品名稱:髖關節假體;預期用途:與該企業同一系統組件配合,適用於髖關節置換,其中雙極頭內襯僅適用於半髖關節置換;有效期至2026年6月23日。
上述產品註冊證的取得,進一步豐富和完善了公司的關節產品線,有利於增強公司在人工關節國家集中帶量採購中的綜合競爭力,預計將對公司未來的經營產生積極影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.